Executive Vice Presidents at Intuitive Surgical (ISRG) and IDEXX Laboratories (IDXX) have recently executed significant stock sales following robust quarterly performance. Myriam Curet, EVP at Intuitive Surgical, liquidated shares totaling approximately $507,000 in a series of transactions starting in December 2025. Meanwhile, IDEXX Laboratories' EVP George Fennell sold 11,345 shares valued at over $7.3 million, representing a 53.6% reduction in his personal holdings. These divestments come on the heels of both companies exceeding analyst expectations for both earnings and revenue in their latest fiscal reports. Despite the insider activity, market sentiment remains positive as both firms retain "Moderate Buy" ratings from Wall Street analysts. Analysts typically view such sales as routine profit-taking or portfolio diversification rather than a signal of fundamental weakness.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis